Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL
Official Title: A Phase 2 Trial of Ixazomib for Kaposi Sarcoma
Brief Summary: This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma.
Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.